Also trades as: PPCBD (OTC) · $vol 0M
PPCB NASDAQ
Propanc Biopharma, Inc.
1W: -19.5%
1M: -50.7%
3M: -73.0%
YTD: -11.2%
1Y: -70.2%
3Y: -100.0%
5Y: -99.0%
$0.51
+0.01 (+1.30%)
Weekly Expected Move ±14.3%
$0
$0
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$6M
-1302.5% ▼
Capital Expenditures
$5K
-246650.0% ▼
5Y CAGR: +315.2%
Free Cash Flow
-$6M
-1302.5% ▼
Dividends Paid
$932K
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$820K
+9213.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$3M | -$2M | -$59M | -$19M |
| Depreciation & Amort. | $6K | $23K | $22K | $5M | $9M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $167K | $473K | $417K | $1M | -$585K |
| Other Non-Cash Items | $1M | $1M | $446K | $53M | $5M |
| Operating Cash Flow | -$1M | -$1M | -$935K | -$405K | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$5K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | -$5K |
| — Financing Activities — | |||||
| Net Debt Issuance | $766K | $590K | $919K | $344K | -$807K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$932K |
| Other Financing | $625K | $499K | $0 | $147K | $932K |
| Financing Cash Flow | $1M | $1M | $942K | $491K | $6M |
| Net Change in Cash | $2K | $6K | $11K | -$9K | $820K |
| Cash End of Period | $4K | $10K | $21K | $12K | $832K |
| Free Cash Flow | -$1M | -$1M | -$935K | -$405K | -$6M |